Tech Company Financing Transactions
Mitochon Pharmaceuticals Funding Round
Ben Franklin Technology Partners and private investors invested in a $1.6 million funding round for Mitochon Pharmaceuticals. This venture round was announced on 5/18/2016.
Transaction Overview
Company Name
Announced On
5/18/2016
Transaction Type
Venture Equity
Amount
$1,600,000
Round
Undisclosed
Investors
Proceeds Purpose
The proceeds from the financing will be used to advance Mitochon's lead compound MP101, a first in class mitochondrial targeted neuro-protective agent, into human studies, as well as, further develop MP201 for IND filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
970 Cross Ln.
Blue Bell, PA 19422
USA
Blue Bell, PA 19422
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Our mission is to bring forward meaningful drugs that work at the root of insidious diseases by modulating the mitochondria directly to attenuate disease progression.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Alonso
Chief Medical Officer
Marcus Keep
Chief Scientific Officer
John Geisler
Browse more venture capital transactions:
Prev: 5/18/2016: Capshare venture capital transaction
Next: 5/18/2016: Teckst venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs